Utility Menu

National Association of Pharmacy Regulatory Authorities

Provinces

Main navigation


Search: National Drug Schedules

Begin your search by using the generic name of the product:

Search by Glossary
Drug Name Comment Schedule Date
IbafloxacinPDL I DEC / 13
Ibandronic acid or its saltsPDL I DEC / 13
Ibogaine or its salts or derivatives or analoguesPDL I MAY / 17
Ibrutinib or its saltsPDL I DEC / 14
Ibuprofen or its saltsPDL I DEC / 13
Ibuprofen or its saltsPDL

except when sold in an oral dosage form that provides 400 mg or less per dosage unit or in a modified-release oral dosage form that provides 600 mg or less per dosage unit for human use

I AUG / 16
Ibuprofen or its salts. when sold in an immediate release dosage form containing 400 mg or less per oral dosage unit (in package sizes exceeding 18,000 mg) III FEB / 12
Ibuprofen or its salts..

when sold in a modified-release oral dosage form that provides 600 mg or less per dosage unit

III AUG / 16
Ibuprofen or its salts... when sold in an immediate release dosage form containing 400 mg or less per oral dosage unit (in package sizes of up to 18,000 mg) U FEB / 12
Ibutilide or its salts and derivativesPDL I DEC / 13
Icatibant or its saltsPDL

including but not limited to Icatibant acetate

I AUG / 14
Idarubicin or its saltsPDL I DEC / 13
IdarucizumabPDL I AUG / 16
IdebenonePDL I DEC / 13
IdelalisibPDL I MAY / 15
IdoxuridinePDL I DEC / 13
IdursulfasePDL I DEC / 13
IfosfamidePDL I DEC / 13
Imatinib and its saltsPDL I DEC / 13
Imidapril or its saltsPDL I DEC / 13
ImiglucerasePDL I DEC / 13
Imipramine or its saltsPDL I DEC / 13
Imiquimod or its saltsPDL I DEC / 13
Immune globulin products I FEB / 02
Immunogenic substancesPDL I DEC / 13
Indacaterol or its salts or derivativesPDL I DEC / 13
Indapamide or its saltsPDL I DEC / 13
Indinavir or its saltsPDL I DEC / 13
IndomethacinPDL I DEC / 13
InfliximabPDL I DEC / 13
Influenza vaccine II DEC / 98
Ingenol mebutate or its derivativesPDL I DEC / 13
Inhaled human insulinPDL I DEC / 13
InosiplexPDL I DEC / 13
Inositol niacinate U DEC / 98
Inotersen or its saltsPDL I NOV / 18
Inotuzumab ozogamicinPDL I MAY / 18
InsulinD II SEP / 98
InterferonPDL I DEC / 13
Iodinated glycerol II SEP / 98
Iodine and its salts and derivatives except topical preparations or in oral doses of 1 mg or less per day II DEC / 98
Iodine and its salts and derivatives for topical use III SEP / 98
Iodochlorhydroxyquin for topical use II SEP / 98
IodochlorohydroxyquinPDL

For veterinary use

I DEC / 13
IodochlorohydroxyquinPDL

except in preparations for topical use on the skin for human use

I DEC / 13
Ipecac and its extracts and derivatives when used as an emetic II OCT / 98
Ipecac and its extracts and derivatives. for use other than as an emetic U OCT / 98
IpilimumabPDL I DEC / 13
Ipratropium or its saltsPDL I DEC / 13
Iproniazid or its saltsPDL I DEC / 13
Irbesartan or its saltsPDL I DEC / 13
Irinotecan or its saltsPDL I DEC / 13
Iron and its salts and derivatives in preparations with more than 30 mg elemental iron per solid dosage unit or 5 mL oral liquid II SEP / 98
Iron and its salts and derivatives. in preparations containing 30 mg or less elemental iron per solid dosage unit or 5 ml oral liquid U
Iron derivativesPDL

for human use, including but not limited to ferumoxytol, iron isomaltoside 1000, for parenteral use only

I DEC / 13
Iron derivativesPDL

for veterinary use, including but not limited to ferumoxytol, for all routes of administration but parenteral

I DEC / 13
Isavuconazole or its saltsPDL I FEB / 19
Isocarboxazid or its saltsPDL I DEC / 13
IsofluranePDL I DEC / 13
IsomethadoneN I JUN / 02
IsoniazidPDL I DEC / 13
Isopropamide and its salts I SEP / 98
Isopropyl myristate in concentration of 50%

for use in the treatment of head lice

III JUL / 07
Isoproterenol (Isoprenaline) or its saltsF1 I DEC / 13
Isosorbide and its salts I SEP / 98
Isotretinoin or its saltsPDL I DEC / 13
Isoxsuprine or its saltsPDL I DEC / 13
Isradipine or its saltsPDL I DEC / 13
Itraconazole or its saltsPDL I DEC / 13
Ivabradine or its salts or derivativesPDL I FEB / 17
Ivacaftor or its derivativesPDL I DEC / 13
Ivermectin and its derivativesF1 for human use or for veterinary use when sold for intramuscular injection into horses or for administration to dogs and cats I MAY / 04
Ixazomib or its derivativesPDL I NOV / 16
IxekizumabPDL I AUG / 16

74 result(s)


Footnotes

  • C1: Drug is in the Controlled Drugs and Substances Act and Part I of the Schedule to Part G of the Food and Drug Regulations
  • C2: Drug is in the Controlled Drugs and Substances Act and Part II of the Schedule to Part G of the Food and Drug Regulations
  • C3: Drug is in the Controlled Drugs and Substances Act and Part III of the Schedule to Part G of the Food and Drug Regulations
  • C4: drug is in the Controlled Drugs and Substances Act
  • C5: drug is in the Regulations Under CDSA
  • CR: drug has been recommended for addition to the Controlled Drugs and Substances Act
  • CR-C: drug has been recommended for addition to the Controlled Drugs and Substances Act, Part G of the Food and Drug Regulations
  • CR-N: drug has been recommend for addition to the Controlled Drugs and Substances Act, Narcotic Control Regulations
  • CR-TS: drug has been recommended for addition to the Controlled Drugs and Substances Act, Benzodiazepines and Other Targeted Substances Regulations
  • F1: drug appears in Part I of Schedule F to the Food and Drugs Act and Regulations
  • F2: drug appears in Part II of Schedule F to the Food and Drugs Act and Regulations
  • FR: drug has been recommended for addition to Schedule F to the Food and Drugs Act and Regulations ("Schedule F Recommended")
  • N: drug is in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
  • NR: drug has not been reviewed by NDSAC
  • PDL: drug is in the Prescription Drug List (effective Dec. 19, 2013)
  • R: drug is in Part J of the Food and Drugs Act and listed in the Controlled Drugs and Substances Act
  • TS: drug is in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
  • U: drug has been reviewed by NDSAC and is unscheduled